{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:25:48Z","timestamp":1792193148092,"version":"4.4.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018096","name":"GOG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijgc.2026.104753","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:31:11Z","timestamp":1778283071000},"page":"104753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners"],"prefix":"10.1016","volume":"36","author":[{"given":"Robert L.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonz\u00e1lez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Slomovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Campbell-Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2026.104753_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/IGC.0b013e3181d3caa8","article-title":"European Network of gynaecological oncological trial groups\u2019 requirements for trials between academic groups and pharmaceutical companies","volume":"20","author":"Vergote","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104753_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/IGC.0b013e31829b87da","article-title":"Roadmap for the European network of gynaecological trial groups (ENGOT) trials","volume":"23","author":"Vergote","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104753_bib3","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/IGC.0000000000000478","article-title":"European Network of Gynaecological Oncological Trial Groups\u2019 requirements for trials between academic groups and industry partners\u2014first update 2015","volume":"25","author":"du Bois","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2026.104753_bib4","unstructured":"The Gynecologic Oncology Group: 43 years of success. The Gynecologic Oncology Group. Accessed April 15, 2026. https:\/\/www.gog.org\/news\/the-gog-foundation-inc-a-half-century-of-transforming-the-standard-of-care50th-anniversary-book."},{"issue":"7","key":"10.1016\/j.ijgc.2026.104753_bib5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/ijgc-2019-000441","article-title":"Joint ENGOT and GOG Foundation requirements for trials with industry partners","volume":"29","author":"Vergote","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104753_bib6","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.3802\/jgo.2023.34.e33","article-title":"The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women\u2019s cancer research organization","volume":"34","author":"Tan","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104753_bib7","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.3802\/jgo.2023.34.e86","article-title":"East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective","volume":"34","author":"Enomoto","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.104753_bib8","unstructured":"Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. International Committee of Medical Journal Editors. Accessed April 15, 2026. https:\/\/www.icmje.org\/recommendations\/."}],"updated-by":[{"DOI":"10.1016\/j.ijgc.2026.104829","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:22:16Z","timestamp":1785356536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26002847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1048891X26002847"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104753","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"104753"}}